Company Profiles

driven by the PitchBook Platform

Longevity Biotech

Description

Provider of a class of therapeutics via an artificial protein technology. The company provides hybridtides, targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.

2010

Founded

PRIVATE

Status

Grant

Latest Deal Type

$350k

Latest Deal Amount

$170k

Total Amount Raised

1

Investors

Description

Provider of a class of therapeutics via an artificial protein technology. The company provides hybridtides, targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.

Website:

www.longevitybiotech.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

3624 Market Street Suite 300 Philadelphia, PA 19104United States +1 (215) 689-1042
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Longevity Biotech's full profile, request a free trial.

Longevity Biotech Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Longevity Biotech Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Breakout LabsVenture CapitalMinority000 0000000 0000
Breakout Labs Venture Capital

Longevity Biotech Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Scott Shandler Ph.DChief Executive Officer, President, Director & Co-Founder
Uma Sinha Ph.DExecutive Vice President, Preclinical Development
Samuel Gellman Ph.DCo-Founder & Head, Peptide Chemistry
Scott Shandler Ph.D Chief Executive Officer, President, Director & Co-Founder
Uma Sinha Ph.D Executive Vice President, Preclinical Development
Samuel Gellman Ph.D Co-Founder & Head, Peptide Chemistry
Request full access to PitchBook